{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:33:31Z","timestamp":1774917211588,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RSP-2021\/103"],"award-info":[{"award-number":["RSP-2021\/103"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.114008","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T02:06:54Z","timestamp":1637978814000},"page":"114008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors"],"prefix":"10.1016","volume":"228","author":[{"given":"Diaaeldin M.","family":"Elimam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6996-4017","authenticated-orcid":false,"given":"Wagdy M.","family":"Eldehna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7316-9278","authenticated-orcid":false,"given":"Rofaida","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Bonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara T.","family":"Al-Rashood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0862-7628","authenticated-orcid":false,"given":"Mahmoud M.","family":"Elaasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9137-2509","authenticated-orcid":false,"given":"Paola","family":"Gratteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba Abdelrasheed","family":"Allam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.114008_bib1","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3109\/13880209.2011.576346","article-title":"Ligusticum chuanxiong Hort: a review of chemistry and pharmacology","volume":"49","author":"Ran","year":"2011","journal-title":"Pharmaceut. Biol."},{"key":"10.1016\/j.ejmech.2021.114008_bib2","first-page":"633","article-title":"Design, synthesis, and biological evaluation of ligustrazine\/resveratrol hybrids as potential anti-ischemic stroke agents","volume":"18","author":"Zhang","year":"2020","journal-title":"Chin. J. Nat. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2021.114008_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jep.2009.06.008","article-title":"Tetramethylpyrazine suppresses interleukin-8 expression in LPS-stimulated human umbilical vein endothelial cell by blocking ERK, p38 and nulear factor-kappaB signaling pathways","volume":"125","author":"Li","year":"2009","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.ejmech.2021.114008_bib4","first-page":"1031","article-title":"[Effect of tetramethylpyrazine on the expression of macrophage migration inhibitory factor in acute spinal cord injury in rats]","volume":"37","author":"Xiao","year":"2012","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.ejmech.2021.114008_bib5","doi-asserted-by":"crossref","first-page":"2124638","DOI":"10.1155\/2016\/2124638","article-title":"Mechanisms and clinical application of tetramethylpyrazine (an interesting natural compound isolated from Ligusticum Wallichii): current status and perspective","author":"Zhao","year":"2016","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"10.1016\/j.ejmech.2021.114008_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1142\/S0192415X12500036","article-title":"Meta-analysis of the clinical effect of ligustrazine on diabetic nephropathy","volume":"40","author":"Wang","year":"2012","journal-title":"Am. J. Chin. Med."},{"issue":"5","key":"10.1016\/j.ejmech.2021.114008_bib7","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1159\/000493712","article-title":"Ligustrazine inhibits growth, migration and invasion of medulloblastoma daoy cells by up-regulation of miR-211","volume":"49","author":"Xu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.114008_bib8","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200199","article-title":"Ligustrazine inhibits the proliferation and migration of ovarian cancer cells via regulating miR-211","volume":"41","author":"Zhang","year":"2021","journal-title":"Biosci. Rep."},{"issue":"5","key":"10.1016\/j.ejmech.2021.114008_bib9","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.3390\/molecules17054972","article-title":"Synthesis and biological evaluation of new ligustrazine derivatives as anti-tumor agents","volume":"17","author":"Wang","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.114008_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2017.04.025","article-title":"Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance","volume":"135","author":"Zha","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/DDDT.S237957","article-title":"Design, synthesis and biological evaluation of new HDAC1 and HDAC2 inhibitors endowed with ligustrazine as a novel cap moiety","volume":"14","author":"Al-Sanea","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2021.114008_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2017.04.025","article-title":"Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance","volume":"135","author":"Zha","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib13","doi-asserted-by":"crossref","first-page":"21035","DOI":"10.3390\/ijms160921035","article-title":"A\u00a0series of new ligustrazine-triterpenes derivatives as anti-tumor agents: design, synthesis, and biological evaluation","volume":"16","author":"Xu","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.114008_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejmech.2017.02.036","article-title":"Combination of amino acid\/dipeptide with ligustrazine-betulinic acid as antitumor agents","volume":"130","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib15","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/acs.jmedchem.5b01203","article-title":"Discovery of new monocarbonyl ligustrazine\u2013curcumin hybrids for intervention of drug-sensitive and drug-resistant lung cancer","volume":"59","author":"Yong","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bmcl.2021.128230","article-title":"Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents","volume":"47","author":"Luo","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.114008_bib17","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.114008_bib18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","article-title":"Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.114008_bib19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/138161208783877893","article-title":"Cancer-associated carbonic anhydrases and their inhibition","volume":"14","author":"Pastorek","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2021.114008_bib20","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acsmedchemlett.7b00399","article-title":"Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases","volume":"12","author":"Nocentini","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.114008_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.04.016","article-title":"Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: selective inhibitors for the tumor-associated hCA IX isoform","volume":"152","author":"Ibrahima","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib22","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","article-title":"Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs","volume":"25","author":"Carta","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bioorg.2018.11.014","article-title":"SLC-0111 enaminone analogues, 3\/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX","volume":"83","author":"Eldehna","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib24","doi-asserted-by":"crossref","first-page":"113360","DOI":"10.1016\/j.ejmech.2021.113360","article-title":"Identification of N-phenyl-2-(phenylsulfonyl) acetamides\/propanamides as new SLC-0111 analogues: synthesis and evaluation of the carbonic anhydrase inhibitory activities","volume":"218","author":"Elbadawi","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejmech.2018.10.068","article-title":"Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents","volume":"162","author":"Eldehna","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib26","doi-asserted-by":"crossref","first-page":"112745","DOI":"10.1016\/j.ejmech.2020.112745","article-title":"3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: design, synthesis, biological and molecular modeling studies","volume":"207","author":"Alkhaldi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib27","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bioorg.2019.04.002","article-title":"Novel synthesized SLC-0111 thiazole and thiadiazole analogues: determination of their carbonic anhydrase inhibitory activity and molecular modeling studies","volume":"87","author":"Abo-Ashour","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib28","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bmc.2019.03.001","article-title":"Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors","volume":"27","author":"Lolak","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib29","doi-asserted-by":"crossref","first-page":"113283","DOI":"10.1016\/j.ejmech.2021.113283","article-title":"Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors","volume":"216","author":"Shaldam","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib30","doi-asserted-by":"crossref","first-page":"113800","DOI":"10.1016\/j.ejmech.2021.113800","article-title":"Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: design, synthesis and biological evaluation","volume":"225","author":"Elimam","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib31","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase I.Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ejmech.2021.114008_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1248\/cpb.c16-00839","article-title":"Synthesis and biological evaluation of danshensu and tetramethylpyrazine conjugates as cardioprotective agents","volume":"65","author":"Wang","year":"2017","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2021.114008_bib34","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1021\/jm00111a030","article-title":"Relative structure-inhibition analyses of the N-benzoyl and N-(phenylsulfonyl) amino acid aldose reductase inhibitors","volume":"34","author":"DeRuiter","year":"1991","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib35","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1080\/14756366.2019.1652282","article-title":"Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino) benzenesulfonamides as carbonic anhydrase isoforms I and II inhibitors","volume":"34","author":"Al-Sanea","year":"2019","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/14756366.2019.1697250","article-title":"Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in\u00a0vitro biological evaluation","volume":"35","author":"Abdelrahman","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib37","doi-asserted-by":"crossref","first-page":"103102","DOI":"10.1016\/j.bioorg.2019.103102","article-title":"Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5 (4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity","volume":"90","author":"Eldehna","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/14756366.2020.1862101","article-title":"Novel oxindole\/benzofuran hybrids as potential dual CDK2\/GSK-3\u03b2 inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies","volume":"36","author":"Eldehna","year":"2021","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/14756366.2020.1743281","article-title":"Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity","volume":"35","author":"Al- Rashood","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib40","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1080\/14756366.2020.1806259","article-title":"Discovery of 3, 6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights","volume":"35","author":"Sabt","year":"2020","journal-title":"\u200f J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib41","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bmc.2016.01.019","article-title":"Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111","volume":"24","author":"Lomelino","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib42","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib43","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.114008_sref44","unstructured":"Schr\u00f6dinger Suite Release 2019-1, Schr\u00f6dinger, LLC, New York, NY, 2019:."},{"key":"10.1016\/j.ejmech.2021.114008_bib44a","unstructured":"Prime, v.5.5;."},{"key":"10.1016\/j.ejmech.2021.114008_bib44b","unstructured":"Maestro v.11.9."},{"key":"10.1016\/j.ejmech.2021.114008_bib44c","unstructured":"Epik, v.4.7."},{"key":"10.1016\/j.ejmech.2021.114008_bib44d","unstructured":"Impact, v.8.2;."},{"key":"10.1016\/j.ejmech.2021.114008_bib44e","unstructured":"Macromodel v.12.3.."},{"key":"10.1016\/j.ejmech.2021.114008_bib44f","unstructured":"Glide, v.8.2.."},{"key":"10.1016\/j.ejmech.2021.114008_bib45","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving Ligand\/isoform matching and selectivity of action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib46","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/14756366.2020.1862102","article-title":"Inhibition of \u03b1-, \u03b2- and \u03b3-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with aromatic sulphonamides and clinically licenced drugs - a joint docking\/molecular dynamics study","volume":"36","author":"Bonardi","year":"2021","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114008_bib47","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/acsmedchemlett.0c00403","article-title":"Benzoxaboroles: new potent inhibitors of the carbonic anhydrases of the pathogenic bacterium Vibrio cholerae","volume":"11","author":"Bonardi","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.114008_bib48","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:32:48Z","timestamp":1759329168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421008576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":54,"alternative-id":["S0223523421008576"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114008","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114008"}}